NLRP3 inhib 
Welcome,         Profile    Billing    Logout  
 7 Companies  6 Products   6 Products   29 Diseases   11 Trials   763 News 


«12...123124125126127128129130131132133134135»
  • ||||||||||  Journal:  Cutting Edge: Mitochondrial Assembly of the NLRP3 Inflammasome Complex Is Initiated at Priming. (Pubmed Central) -  Apr 11, 2019   
    An NLRP3 activation signal is then required for the calcium-dependent association of the adaptor molecule ASC with NLRP3 on the mitochondrial surface, resulting in inflammasome complex assembly and activation. These findings demonstrate a novel lipid interaction for caspase-1 and identify a role for mitochondria as supramolecular organizing centers in the assembly and activation of the NLRP3 inflammasome.
  • ||||||||||  Journal:  Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae. (Pubmed Central) -  Apr 11, 2019   
    The Nlrp3 inflammasome is a crucial component of the innate immune system that provokes release of the IL-1β cytokine from myeloid cells upon encountering C. albicans hyphae. Our study reveals the peptide candidalysin as one of the hypha-derived drivers of Nlrp3 inflammasome responses in primary macrophages and, thus, contributes to better understanding the fungal mechanisms that determine the pathogenicity of C. albicans.
  • ||||||||||  Clinical, Review, Journal:  Calcium-Containing Crystals and Osteoarthritis: an Unhealthy Alliance. (Pubmed Central) -  Apr 11, 2019   
    BCP crystals have been demonstrated to induce key mitogenic and inflammatory pathways and contribute to cartilage degradation. Calcium-containing crystals induce key inflammatory pathways and may represent an attractive novel target in OA, a condition devoid of effective treatments.
  • ||||||||||  Journal:  RORγ Regulates the NLRP3 Inflammasome. (Pubmed Central) -  Apr 11, 2019   
    Additionally, RORg inverse agonists reduced mortality in a LPS/D-galactosamine induced fulminant hepatitis mouse model.  These results illustrate a major role for RORgin regulation of innate immunity via modulation of NLRP3 inflammasome activity.  Furthermore, these data suggest that inhibiting the NLRP3 inflammasome with RORginverse agonists may be an effective method to treat NLRP3 associated diseases.
  • ||||||||||  Review, Journal:  Roles of ginsenosides in inflammasome activation. (Pubmed Central) -  Apr 10, 2019   
    Given this body of evidence, the functional relationship between ginsenosides and inflammasome activation provides new insight into the understanding of the molecular mechanisms of ginsenoside-mediated antiinflammatory actions. This relationship also has applications regarding the development of antiinflammatory remedies by ginsenoside-mediated targeting of inflammasomes, which could be used to prevent and treat inflammatory diseases.
  • ||||||||||  Journal:  Activation of NLRP3 signaling accelerates skin wound healing. (Pubmed Central) -  Apr 10, 2019   
    Scratch assay revealed that ATP accelerated wound closure in mouse embryonic fibroblasts from WT mice but not from NALP3-KO mice. In conclusion, the present study demonstrated that NALP3 pathway activation is involved in wound repair, and the topical use of ATP may be useful as an effective treatment for accelerating wound healing.
  • ||||||||||  Solodyn (minocycline) / Bausch Health
    Journal:  Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. (Pubmed Central) -  Apr 10, 2019   
    The involvement of two distinct cell death pathways in RPE sheds light on the potential interplay between these pathways and provides insights on the future development of therapeutic strategies for AMD. These results together indicate that microglial activation mediates the chronic mild stress-induced depressive- and anxiety-like behavior and hippocampal neuro-inflammation.
  • ||||||||||  Kineret (anakinra) / SOBI, Affibody, Ilaris (canakinumab) / Novartis
    Journal:  Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade. (Pubmed Central) -  Apr 10, 2019   
    Together, these findings suggest that patients with epilepsy responsive to immune modulation may have distinct autoinflammatory features supporting IL-1 blockade. As such, IL-1 blockade may be highly efficacious adjunctive medication for certain refractory epilepsy syndromes.
  • ||||||||||  Review, Journal:  Gain of function mutation and inflammasome driven diseases in human and mouse models. (Pubmed Central) -  Apr 9, 2019   
    Furthermore, novel inhibitors of inflammasome complex formation such as MCC950 and related compounds attenuate experimental and clinical disease. The discovery of new GOF mutants of inflammasomes leading to further insights in pathomechanisms and the development of novel inhibitors represent a great challenge.
  • ||||||||||  Journal, IO Biomarker:  Serum amyloid A primes microglia for ATP-dependent interleukin-1β release. (Pubmed Central) -  Apr 9, 2019   
    P2XR-triggered IL-1β maturation and export is thus likely to represent an important contributor to this cytokine pool. Given that SAA is detected in Alzheimer disease and multiple sclerosis brain, together with IL-1β-immunopositive microglia, these findings propose a link between P2XR, SAA, and IL-1β in CNS pathophysiology.
  • ||||||||||  Journal:  Role of complement C5a and histones in septic cardiomyopathy. (Pubmed Central) -  Apr 9, 2019   
    Many of these events occur after in vivo or in vitro contact of CMs with histones. Together, these data emphasize the role of complement (C5a) and C5a receptors (C5aR1, C5aR2), as well as extracellular histones in events that lead to cardiac dysfunction of sepsis (septic cardiomyopathy).
  • ||||||||||  Review, Journal:  NLRP3 inflammasome activation in inflammaging. (Pubmed Central) -  Apr 9, 2019   
    Here, we summarize the current knowledge of mechanisms that drive both of these processes and focus our discussion the emerging concept that a key innate immune pathway, the NLRP3 inflammasome, is centrally involved in the recognition of triggers that appear during physiological aging and during metabolic stress. We further discuss how these processes are involved in the pathogenesis of common age-related pathologies and highlight potential strategies by which the detrimental inflammatory responses could be pharmacologically addressed.
  • ||||||||||  metformin / generics
    Journal:  Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. (Pubmed Central) -  Apr 9, 2019   
    We further discuss how these processes are involved in the pathogenesis of common age-related pathologies and highlight potential strategies by which the detrimental inflammatory responses could be pharmacologically addressed. By targeting AMPK, piperine significantly suppressed the activation of NLRP3 inflammasome, inhibited the release of pro-inflammatory cytokines, blocked the pyroptosis of tubular epithelial cells, and thus suppressed the development of LN.
  • ||||||||||  Journal:  The role of cell-crystal reaction mediated inflammation in the formation of intrarenal calcium oxalate crystals (Pubmed Central) -  Apr 7, 2019   
    Recent studies indicated that inflammation induced by cell-crystal reaction can cause renal cell damage, stimulate intracellular expression of NADPH oxidase, trigger the massive production of reactive oxygen species, activate nuclear factor-κB signaling pathway, release a large number of inflammatory factors, and cause inflammatory cascade effect of the kidney, thus promoting the accumulation, nucleation and growth of calcium salt crystals, eventually leading to the formation of intrarenal crystals and even stones. In this process, the regulatory factors and mechanisms involved include macrophages, NLRP3-high mobility group box-1 protein inflammation network, fetuin A, autophagy activation and other factors.
  • ||||||||||  Journal:  Chlorogenic acid methyl ester exerts strong anti-inflammatory effects via inhibiting the COX-2/NLRP3/NF-κB pathway. (Pubmed Central) -  Apr 7, 2019   
    In addition, CME affected the RAW264.7 cell cycle and inhibited the protein expressions of COX-2 and NLRP3 and prevented the phosphorylation of NF-κB p65 in RAW264.7 cells treated with LPS. These observations not only validated the anti-inflammatory effects of CME, but also revealed the underlying molecular basis, which involves the down-regulation of the expression of inflammatory factors and blockade of the COX-2/NLRP3/NF-κB signaling pathway.
  • ||||||||||  Journal:  NLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma. (Pubmed Central) -  Apr 5, 2019   
    Collectively, we demonstrated here that activation of NLRP3 was engaged in the promotion of asthma. NLRP3, but not the inflammasome adaptor ASC or caspase-1, promoted the polarization of M2 macrophages through up-regulating the expression of IL-4, thereby contributing to its regulation of asthma.
  • ||||||||||  Kolchin (colchicine) / Incepta
    Preclinical, Journal:  Effect of Electroacupuncture on Synovial M 1/M 2 Macrophage Polarization in Rats with Acute Gouty Arthritis (Pubmed Central) -  Apr 5, 2019   
    These results highlight the crucial role of both proteases in IL-1β processing, via inflammasome-dependent and -independent mechanisms. EA intervention can up-regulate the expression of arginase-1 mRNA and p-AMPKα protein, and down-regulate the expression of NOS 2, IL-1 β and NLRP 3 mRNAs in synovial tissues in AGA rats, which may contribute to its anti-inflammatory effect by promoting conversion of macrophages from M 1 pro-inflammatory phenotype to M 2 anti-inflammatory phenotype.